Beyond the border: the use of lenvatinib in advanced hepatocellular carcinoma after different treatment lines: a retrospective analysis

• Autorzy: Jefremow A. , Wiesmueller M. , Rouse R.A. , Dietrich p. , Kremer A.E. , Waldner M.J. , Neurath M.F. , Siebler J.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

hepatocellular carcinoma; tyrosine kinase inhibitor; lenvatinib; treatment; liver cancer; cholangiocarcinoma; patient

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2020
• Tom: 71
• Numer: 5
• Opis fizyczny: p.717-728,fig.,ref.

Twórcy

autor

Jefremow A.

• Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Erlangen, Germany
• Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany

autor

Wiesmueller M.

• Institute of Radiology, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Erlangen, Germany

autor

Rouse R.A.

• Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Erlangen, Germany
• Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany

autor

Dietrich p.

• Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Erlangen, Germany
• Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany
• Institute of Biochemistry (Emil-Fischer-Zentrum), Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Erlangen, Germany

autor

Kremer A.E.

• Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Erlangen, Germany
• Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany

autor

Waldner M.J.

• Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Erlangen, Germany
• Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany

autor

Neurath M.F.

• Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Erlangen, Germany
• Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany

autor

Siebler J.

• Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universitaet Erlangen-Nuremberg, Erlangen, Germany
• Deutsches Zentrum Immuntherapie (DZI), Erlangen, Germany

Identyfikatory

DOI

10.26402/jpp.2020.5.11